Atlas Trials

An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

Clinical trial NCT00789711 · COMPLETED

Trial details

NCT number
NCT00789711
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2008-11-01
Primary completion
2009-08-01
Enrollment
3131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.